Neurobit
@StudyMysleep
Health Analytics | Population Health | Clinical Trials Support | Sleep Biomarker
你可能會喜歡
Exciting advancements in #Narcolepsy treatment! From orexin receptor agonists like TAK-925 to innovative wearable tech, new therapies are emerging. Key players like @Alkermes, @HarmonyBio, @zevratx, and @axsome are making advancements.
Press Release - Neurobit Secures US Patent for AI System Enhancing Diagnostic Efficiency in Hospitals and Clinics. Read it here: neurobit.com/press/neurobit…
Press Release - Neurobit Secures US Patent for AI System Enhancing Diagnostic Efficiency in Hospitals and Clinics. #Biomarkerbridge Read it here: neurobit.com/press/neurobit…
We at Neurobit are excited to announce that we’ve been granted a US Utility Patent for our AI-powered system revolutionizing sleep diagnostics! get licence to use this patent here : neurobit.com/psg #SleepDiagnostics #Innovation #HealthcareRevolution #Neurobit #Patent
At #Neurobit we’re leveraging tech like wearable devices for medical diagnosis and patient care. To learn more, check out our blog, which outlines research by Aydin Zahedivash on the use of wearables in detecting arrhythmias among pediatric patients. neurobit.com/blog/researchb…
Read our article, which explores the implications of the relationship between sleep regularity, OSA and hypertension. Discover the latest research and gain insight on managing and preventing health issues. neurobit.com/blog/researchb… #SleepApnea #Neurobit #Research
Getting sufficient, restful sleep is essential for good cardiovascular health. Sleep disorders like insomnia, narcolepsy and sleep apnea increase the risk of CVD. Learn more about the effects here: heart.org/-/media/Files/… #raredisease #Narcolepsy #SleepApnea
Did you know 12% of Americans have been diagnosed with chronic insomnia? This was presented at the annual Insomnia Awareness Night by AASM. Thank you to @AASMorg for raising awareness #InsomniaAwarnessNight #insomnia
Developments in Narcolepsy Research! Alkermes' ALKS 2680 shows promise in Phase 2 for NT1. Takeda advances TAK-861 to Phase 3, targeting daytime sleepiness & cataplexy. #Neurobit #NarcolepsyResearch
Did you know? It takes an average of seven years to diagnose #narcolepsy, leading to misdiagnosis in up to 60% of cases. Learn more about this disorder and recent breakthroughs in our article #Neurobit #raredisease #Research neurobit.com/blog/researchb…
Regularity in sleep is emerging as a game-changer in sleep medicine. It's about creating a consistent sleep-wake cycle to support our body's natural rhythms and health. #consistency
United States 趨勢
- 1. $NVDA 77.5K posts
- 2. Jensen 24.8K posts
- 3. Peggy 38.5K posts
- 4. GeForce Season 5,857 posts
- 5. NASA 54.6K posts
- 6. #ใครในกระจกEP5 9,430 posts
- 7. #YIAYalpha N/A
- 8. Sumrall 2,441 posts
- 9. Arabic Numerals 4,324 posts
- 10. Stargate 7,189 posts
- 11. #WickedWaysToMakeABuck N/A
- 12. Martha 20.1K posts
- 13. Comey 58.3K posts
- 14. Saba 11K posts
- 15. Poverty 54.5K posts
- 16. Sam Harris N/A
- 17. Kwame 6,573 posts
- 18. Judge Smith 2,992 posts
- 19. #WWESuperCardNewSeason 1,162 posts
- 20. #2Kgiveaway 1,161 posts
Something went wrong.
Something went wrong.